Home > Boards > US OTC > Medical - Drugs >

Innovation Pharmaceuticals Inc. (IPIX)

IPIX RSS Feed
Add IPIX Price Alert      Hide Sticky   Hide Intro
Moderator: zandant, LilKahuna, BooDog, TheHound, frrol, Lemoncat
Search This Board: 
Last Post: 10/21/2019 9:16:53 PM - Followers: 758 - Board type: Free - Posts Today: 38

Innovation Pharmaceuticals Inc. (IPIX)

SEC Filings  https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany

 

http://www.ipharminc.com/

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@ipharminc.com

 
About Innovation Pharmaceuticals Inc.: 

Headquartered in Beverly, Massachusetts, Innovation Pharmaceuticals is a publicly-traded company under the symbol "IPIX".
Innovation Pharmaceuticals is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Innovation Pharmaceuticals believes it has a world-class portfolio of first-in-class lead drug candidates and is now advancing them toward market approval, while actively seeking strategic partnerships. Innovation Pharmaceuticals' anti-cancer drug Kevetrin successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers' Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Innovation Pharmaceuticals has commenced a Phase 2 study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the "Guardian Angel Gene" due to its crucial role in controlling cell mutations. Innovation Pharmaceuticals is in a Phase 2 clinical trial with its novel compound Brilacidin-OM (a defensin mimetic compound) for the prevention of oral mucositis in patients with head and neck cancer. Interim analysis has shown Brilacidin-OM to have a high potential for prevention of severe oral mucositis. Clinical results are consistent with those seen in an animal model in which the occurrence of severe ulcerative oral mucositis was reduced by more than 94% compared to placebo. Innovation Pharmaceuticals' lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria ("superbugs"). In an ongoing Phase 2 open label Proof-of-Concept trial, favorable interim results have been observed in the first two cohorts of patients treated with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two types of Inflammatory Bowel Disease (IBD).  Innovation Pharmaceuticals has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available at http://www.ipharminc.com.

Management:  http://www.ipharminc.com/senior-management/

Scientific Advisors:  http://www.ipharminc.com/scientific-advisors/

Clinical Trials:  https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%2C+Inc.%22++&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Trials under previous name:   https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps

 
Product Pipeline:  http://www.ipharminc.com/therapeutic-areas/

PIPELINE: 
CLICK TO VIEW LARGER IMAGE

 

FDA DESIGNATIONS:

 

Stages of development:

stages-v2.jpg


Recent News and Press Releases: 
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/

 
SEC Filings (CIK:0001355250): 
https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com

 
Share Structure:  See SEC filing link above for current share structure

 

Innovation Pharmaceuticals IP



Patent Filings:


EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet

http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations: 

http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1


Chart:   https://stockcharts.com/h-sc/ui?s=IPIX

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

IPIX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IPIX News: Post-effective Amendment to Registration Statement (pos Am) 10/17/2019 05:24:36 PM
IPIX News: Annual Report (10-k) 09/30/2019 04:38:42 PM
IPIX News: Post-effective Amendment to Registration Statement (pos Am) 09/20/2019 04:36:18 PM
IPIX News: Current Report Filing (8-k) 09/20/2019 04:34:50 PM
IPIX News: Statement of Changes in Beneficial Ownership (4) 09/06/2019 04:52:17 PM
PostSubject
#273433  Sticky Note Still here...? That's funny... With 150M votes supporting steelyeye 09/26/19 12:09:04 AM
#267390  Sticky Note The other point which makes this more significant farrell90 07/13/19 01:38:49 PM
#253731  Sticky Note “The Misleading” – Daily Short Volume sox040713 01/08/19 08:51:48 PM
#253363  Sticky Note Sometimes it helps to looks at some of Lemoncat 01/03/19 09:06:01 PM
#249866  Sticky Note BOARD WARNING: Please read - IH Admin [Shelly] 11/26/18 10:31:07 AM
#274985   Keep the faith George! Good things come to Lemoncat 10/21/19 09:16:53 PM
#274984   Big cry baby. scottsmith 10/21/19 09:15:43 PM
#274983   IPIX and Pfizer!!! georgejjl 10/21/19 09:01:31 PM
#274982   Boy am I surpised. 58nout 10/21/19 08:11:12 PM
#274978   Will we get news this week? snayeman 10/21/19 07:00:41 PM
#274977   FINRA short sales of IPIX AlanC 10/21/19 06:30:58 PM
#274976   Probably DCA into this name lol scottsmith 10/21/19 05:33:13 PM
#274975   Savvy investment of 180 bucks.... noretreat 10/21/19 05:04:40 PM
#274973   Leo has no game plan other than to MXAMDUD 10/21/19 03:24:24 PM
#274972   You can fill this out. You never know, ZROYPU 10/21/19 03:13:07 PM
#274971   down another 7%. great job Leo MXAMDUD 10/21/19 03:01:48 PM
#274970   https://www.sigmaaldrich.com/catalog/product/sigma/sml2184?lang=en&region=US PJ007 10/21/19 02:01:41 PM
#274969   here comes the 8's MXAMDUD 10/21/19 01:49:45 PM
#274967   Yes ok. Thank you. Now I saw it. Papaul21 10/21/19 11:35:01 AM
#274966   Do a member search for L2 hunter or TheDane 10/21/19 11:21:04 AM
#274965   That WILL/WOULD be amazing to see!! Looking BooDog 10/21/19 10:52:44 AM
#274963   Shorties should be very scared and running for MXAMDUD 10/21/19 10:44:20 AM
#274962   I cannot open your link. Can you give Papaul21 10/21/19 10:36:23 AM
#274961   Another lame day, come on Leo! snayeman 10/21/19 10:34:40 AM
#274960   Or too early. TheDane 10/21/19 09:43:53 AM
#274959   A great swing trade for the adventurous! Don't Lemoncat 10/21/19 09:38:42 AM
#274958   Now 41k. Hmm. TheDane 10/21/19 09:36:17 AM
#274957   Swell. We have 141k at the bid of TheDane 10/21/19 09:33:46 AM
#274955   We’re Golden! We got the attention of Multi-Bagger-Alerts... TheDane 10/21/19 09:07:40 AM
#274954   Let's hope lizard jogging gets a deal for Paddleboarder 10/21/19 08:51:55 AM
#274953   I've heard that before and I'm still not loanranger 10/21/19 08:40:27 AM
#274952  Restored This zombie stock will wander another week and MXAMDUD 10/21/19 08:38:00 AM
#274950   The conclusions are slightly different: ZROYPU 10/21/19 06:03:32 AM
#274949   That is the old poster from 2017, here ZROYPU 10/21/19 05:12:15 AM
#274947   Only honest response to that is someone fell kfcyahoo 10/20/19 11:27:38 PM
#274946   Ugh? TheDane 10/20/19 09:24:53 PM
#274941   "IPIX thought they had a deal and extended loanranger 10/20/19 06:14:24 PM
#274940   If that's the case there is a pretty Lemoncat 10/20/19 06:09:06 PM
#274939   I cannot reveal my sources otherwise it may Lemoncat 10/20/19 06:06:45 PM
#274938   Chart is priced for bankruptcy at best and scottsmith 10/20/19 06:01:23 PM
#274937   All nonsense and fantasy. Zero facts. scottsmith 10/20/19 05:01:19 PM
#274935   IPIX CHART >>> l2 hunter 10/20/19 03:48:00 PM
#274932   I was giving our sad CEO the benefit zandant 10/20/19 01:57:38 PM
#274930   Good points, particularly given Leo’s penchant for exaggerated zandant 10/20/19 12:53:53 PM
#274928   Though I got into this stock because of Empiricst1 10/20/19 11:30:52 AM
#274927   Can't wait for the Monday opening of the JTORENCE 10/20/19 11:22:09 AM
#274926   Williamssc this is just a research paper. If JTORENCE 10/20/19 11:20:16 AM
#274925   Perhaps this will shed a little more light CallMeCrazy 10/20/19 11:20:07 AM
#274923   Kevetrin isn't 'dead'? Didn't that award winning Snowy_Owl 10/20/19 09:09:19 AM
#274922   “ Summary/Conclusion: TheDane 10/20/19 08:38:45 AM
#274921   That helps. Thank! It will be nice to TheDane 10/20/19 08:34:59 AM
#274920   All these Dr's with the exception of Menon ZROYPU 10/20/19 08:01:00 AM
#274919   Here is what may be the article. Not Empiricst1 10/20/19 04:32:13 AM
#274918   Often the posters are just that, posters, similar Empiricst1 10/20/19 04:16:22 AM
#274917   Interesting, Z and thanks for the link. zandant 10/20/19 02:25:39 AM
PostSubject